Tazidime and Zyprexa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tazidime (ceftazidime) and Zyprexa (olanzapine). Common drug interactions include thrombocytopenia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Tazidime and Zyprexa. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Zyprexa?

Zyprexa has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 64,724 Zyprexa users. Check the latest studies of Zyprexa.



On Jul, 13, 2026

20 people who take Tazidime and Zyprexa together, and have interactions are studied.

Tazidime and Zyprexa drug interactions.

What are the common drug interactions of Tazidime and Zyprexa, by gender? *:

female:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Urinary tract infection
  3. Vomiting
  4. Wound infection
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  7. Abdominal distension
  8. Abdominal pain upper
  9. Abscess (pus)
  10. Alpha haemolytic streptococcal infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans)

male:

  1. Pneumonia
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
  4. Constipation
  5. Cough
  6. Cystic fibrosis (disease of the secretary glands)
  7. Diarrhoea
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Dyspnoea (difficult or laboured respiration)
  10. Gastroenteritis norovirus (inflammation of stomach and intestine caused by norovirus infection)

What are the common drug interactions of Tazidime and Zyprexa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Abdominal pain upper
  4. Asthenia (weakness)
  5. Atelectasis (partial or complete collapse of the lung)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Blood glucose increased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Cardiac failure congestive
  10. Cardiomegaly (increased size of heart than normal)

30-39:

  1. Acidosis (build-up of carbon dioxide in the blood)
  2. Acute respiratory distress syndrome
  3. Anaemia (lack of blood)
  4. Asthenia (weakness)
  5. Bandaemia (excess of band cells (immature white blood cells) released by the bone marrow into the blood)
  6. Blood creatinine increased
  7. Blood urea increased
  8. Bronchial haemorrhage (bleeding in bronchia)
  9. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
  10. Constipation

40-49:

  1. General physical health deterioration (weak health status)
  2. Gingival bleeding (bleeding gums)
  3. Granuloma (a small area of inflammation due to tissue injury)
  4. Haematochezia (passage of stools containing blood)
  5. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  6. Hepatic cyst
  7. Hepatic lesion
  8. Hepatic neoplasm malignant (liver cancer)
  9. Hepatic steatosis (fatty liver disease)
  10. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)

50-59:

  1. Lymphoma (cancer that begins in immune system cells)
  2. Septic shock (shock due to blood infection)

60+:

  1. Blood creatine phosphokinase increased
  2. Fall
  3. Decreased appetite
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Gastric ulcer (stomach ulcer)
  6. Lung neoplasm malignant (cancer tumour of lung)
  7. Pancreatitis acute (sudden inflammation of pancreas)
  8. Pneumonia
  9. Renal failure (kidney dysfunction)
  10. Vertigo

What are the existing conditions these people have? *

  1. High Blood Pressure: 11 people, 55.00%
  2. Fungal Infection: 10 people, 50.00%
  3. Cough: 10 people, 50.00%
  4. Inflammation: 10 people, 50.00%
  5. Wheezing (a high-pitched whistling sound made while you breath): 9 people, 45.00%
  6. Asthma: 9 people, 45.00%
  7. Cystic Fibrosis (disease of the secretary glands): 9 people, 45.00%
  8. Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 9 people, 45.00%
  9. Pain: 9 people, 45.00%
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 9 people, 45.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and Zyprexa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tazidime and Zyprexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zyprexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tazidime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zyprexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime and olanzapine (the active ingredients of Tazidime and Zyprexa, respectively), and Tazidime and Zyprexa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: